University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

A Multicenter Study of NAP (AL-108) in Schizophrenia

Phase 2

Completed

Conditions: Schizophrenia

Interventions: Drug: Placebo
Drug: AL-108

First Posted Date: 2007-07-23

Last Posted Date: 2017-03-10

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 63

Registration Number: NCT00505765

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States
🇺🇸
Maryland Psychiatric Research Center, Catonsville, Maryland, United States
🇺🇸
Columbia University Medical Center, New York, New York, United States

and more 5 locations

Treatment Study for Cognitive Deficits in Schizophrenia

Phase 2

Completed

Conditions: Schizophrenia

Interventions: Drug: MK-0777
Drug: placebo

First Posted Date: 2007-07-20

Last Posted Date: 2014-10-31

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 63

Registration Number: NCT00505076

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States
🇺🇸
Harvard Medical School, Boston, Massachusetts, United States
🇺🇸
UCLA, Los Angeles, California, United States

and more 5 locations

Educational Technology to Enhance Diabetes Care - Retention Study

Not Applicable

Completed

Conditions: Diabetes Mellitus

First Posted Date: 2007-05-08

Last Posted Date: 2007-05-08

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 105

Registration Number: NCT00470860

Locations: 🇺🇸
Charles R. Drew University, Los Angeles, California, United States
🇺🇸
UCLA Medical Center, Los Angeles, California, United States

Modafinil vs Placebo for the Treatment of Methamphetamine Dependence

Phase 2

Completed

Conditions: Methamphetamine Dependence

Interventions: Drug: Placebo
Drug: Modafinil

First Posted Date: 2007-05-04

Last Posted Date: 2020-03-02

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 71

Registration Number: NCT00469508

Locations: 🇺🇸
UCLA Vine Street Clinic, Hollywood, California, United States

Reducing Health Risk Behavior and Improving Health in Adolescents With Depression

Phase 1

Completed

Conditions: Depression
Adolescent Health

Interventions: Other: Treatment as usual
Behavioral: Behavioral health intervention

First Posted Date: 2007-04-18

Last Posted Date: 2022-11-03

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 217

Registration Number: NCT00461539

Locations: 🇺🇸
University of California, Los Angeles, Semel Institute for Neuroscience and Human Behavior, Los Angeles, California, United States
🇺🇸
Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States

Integrated Behavioral Therapy for Treating Children With Selective Mutism

Not Applicable

Completed

Conditions: Selective Mutism

Interventions: Behavioral: Integrated behavioral therapy (BT)

First Posted Date: 2007-04-09

Last Posted Date: 2016-11-28

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 21

Registration Number: NCT00458198

Locations: 🇺🇸
300 UCLA Medical Plaza, Los Angeles, California, United States

A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)

Phase 2

Completed

Conditions: Relapsing Remitting Multiple Sclerosis

Interventions: Drug: Placebo
Drug: Estriol
Drug: Copaxone

First Posted Date: 2007-03-23

Last Posted Date: 2016-06-16

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 158

Registration Number: NCT00451204

Locations: 🇺🇸
Western Institute for Biomedical Research, Salt Lake City, Utah, United States
🇺🇸
University of Texas Southwestern, Dallas, Texas, United States
🇺🇸
Dartmouth Medical School, Lebanon, New Hampshire, United States

and more 13 locations

Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder

Phase 4

Completed

Conditions: Attention Deficit Disorder With Hyperactivity

Interventions: Drug: Methylphenidate (MPH)
Drug: Guanfacine

First Posted Date: 2007-01-31

Last Posted Date: 2021-07-30

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 212

Registration Number: NCT00429273

Locations: 🇺🇸
University of California Los Angeles, Los Angeles, California, United States

Assisting HIV-infected Mothers in Disclosing Their Serostatus to Their Children

Phase 1

Completed

Conditions: HIV

Interventions: Behavioral: Teaching, Raising, and Communicating with Kids (TRACK)
Other: Treatment as usual

First Posted Date: 2007-01-31

Last Posted Date: 2013-06-26

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 160

Registration Number: NCT00429546

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Walking Study for Stroke Rehabilitation

Phase 1

Completed

Conditions: Stroke

Interventions: Behavioral: Daily reinforcement of walking speed (DRS)
Behavioral: No reinforcement of walking speed (NRS)

First Posted Date: 2007-01-30

Last Posted Date: 2011-11-11

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 216

Registration Number: NCT00428480

Locations: 🇺🇸
The Rehabilitation Institute of Chicago, Chicago, Illinois, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
St. Luke's and Whiteside Institute for Clinical Research, Duluth, Minnesota, United States

and more 21 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy